Vanadium in diabetes: 100 years from Phase 0 to Phase I.

@article{Thompson2006VanadiumID,
  title={Vanadium in diabetes: 100 years from Phase 0 to Phase I.},
  author={Katherine H. Thompson and Chris Orvig},
  journal={Journal of inorganic biochemistry},
  year={2006},
  volume={100 12},
  pages={1925-35}
}
A little over one hundred years ago, a vanadium-containing compound was assessed clinically for use in treatment of human diabetic patients. The results were somewhat ambiguous, but nonetheless, intriguing. In 2000, the first Phase I clinical trial of a designed vanadium-based pharmaceutical agent (bis(ethylmaltolato)oxovanadium(IV), BEOV), was completed by Medeval Ltd., Manchester, UK. Results here, too, were promising, but not without some difficult remaining questions. In this review, we… CONTINUE READING

From This Paper

Topics from this paper.
54 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

Similar Papers

Loading similar papers…